Nab-Paclitaxel (Abraxane®, Ebetaxel®) as first-line therapy for metastatic adenocarcinoma of the pancreas
Semlitsch T, Zengerer A, Jeitler K
Record ID 32014000458
English
Authors' objectives:
Maintenance of the programme as standard practice at the LBI-HTA by regular scanning of information sources, 3-monthly prioritization rounds, quarterly compilation of assessments on relevant oncologic drugs and dissemination of the reports.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://eprints.hta.lbg.ac.at/1023/1/DSD_HSO_Nr.43.pdf
URL for additional information:
http://hta.lbg.ac.at/page/horizon-scanning-in-der-onkologie
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Austria
MeSH Terms
- Humans
- Paclitaxel
- Pancreatic Neoplasms
Contact
Organisation Name:
Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address:
Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name:
tarquin.mittermayr@aihta.at
Contact Email:
office@aihta.at
Copyright:
Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.